stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Lineage Cell Therapeutics IncLCTX
$0.795113.07%-0.1195

Lineage Cell Therapeutics Inc (LCTX)

Finanzdaten der Lineage Cell Therapeutics Inc-Aktie (LCTX)

*Alle Zahlen in Millionen
Enddatum des Zeitraums2026-09-302026-06-302026-03-312025-12-312025-09-30
Periodenlänge3 Monate3 Monate3 Monate3 Monate3 Monate
Revenues
34.14%1.43
1.071.736.613.68
20.03%3.82
4.774.23--
Research and Development
20.03%3.82
4.774.23--
Costs And Expenses
12.45%8.75
9.999.3213.167.47
Depreciation and Amortization
8.02%0.20
0.190.190.190.18
Operating Income/Loss
18.03%-7.31
-8.92-7.59-6.55-3.79
Nonoperating Income/Loss
14.91%12.03
10.472.802.16-25.97
Income/Loss From Continuing Operations Before Tax
4.71
---4.39-29.75
Income Tax Expense/Benefit
0.48
----
173.96%4.23
1.54-4.790.89-29.75
Attributable To Parent
185.56%4.23
1.48-4.810.85-29.78
Available To Common Stockholders, Basic
185.56%4.23
1.48-4.810.85-29.78
Attributable To Noncontrolling Interest
103.23%-0.00
0.060.020.040.03
Basic Average Shares
1.37%252.91
249.50245.032.35228.85
Diluted Average Shares
0.92%259.08
261.47261.182.35228.85
Basic Earnings Per Share
100.00%0.02
0.01-0.02--0.13
Diluted Earnings Per Share
-0.03
-0.03-0.03--0.13

Ähnlich wie LCTX